ArticleBone marrow transplantation2024

Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies.

Satoshi Kaito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.